Dose-response and efficacy ceiling of zilebesiran: a bayesian non-linear spline meta-analysis of phase 1 and KARDIA phase 2 trials

zilebesiran (ALN-AGT) - Alnylam, Roche

https://digital-congress.escardio.org/ESC-Congress/Sessions/20241

K Keswani1; A Bakhsh 2; M N ELshabrawi 3; K H Wong4; A Agarwal5; E Alupei6; D S Rajawat7; R K Patel8; V D K Veldi9; P Kusimw'iragi10; H W Saqib11; M Yathindra 12; M Pasha13; N A Doshi14; A Das15

May 11, 2026